Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug

Introduction: Cancer drug delivery has limitations of delivering hydrophobic anticancer drugs and non-targeted adverse effects to normal tissues. This work explores the self-assembling peptide EAK16-II for delivery of hydrophobic anticancer drug ellipticine in human lung carcinoma A549 cells. Hyp...

Full description

Bibliographic Details
Main Author: Bawa, Roli
Other Authors: Liu, Mingyao
Language:en_ca
Published: 2009
Online Access:http://hdl.handle.net/1807/30120
id ndltd-LACETR-oai-collectionscanada.gc.ca-OTU.1807-30120
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-OTU.1807-301202013-04-17T04:20:35ZSelf-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer DrugBawa, RoliIntroduction: Cancer drug delivery has limitations of delivering hydrophobic anticancer drugs and non-targeted adverse effects to normal tissues. This work explores the self-assembling peptide EAK16-II for delivery of hydrophobic anticancer drug ellipticine in human lung carcinoma A549 cells. Hypothesis: Self-assembling peptide based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through an endocytotic mechanism. Methods: EAK16-II and ellipiticine were formulated in water, and size and morphology determined using transmission electron microscopy and dynamic light scattering. The anticancer activity was evaluated by MTS assay. The cellular uptake and subcellular distribution of drug was characterized using endocytotic inhibitors and trackers. Results: EAK16-II can form nanoparticles with ellipticine and has comparable anticancer activity to ellipticine in DMSO. Nano-formulation has enhanced drug uptake through the caveolin dependent pathway. The drug localizes to lysosome and target organelles. Conclusion: EAK16-II forms nanoparticles with the drug and enhances cellular uptake through a caveolin-dependent endocytotic mechanism.Liu, Mingyao2009-112011-11-30T18:00:59ZWITHHELD_TWO_YEAR2011-11-30T18:00:59Z2011-11-30Thesishttp://hdl.handle.net/1807/30120en_ca
collection NDLTD
language en_ca
sources NDLTD
description Introduction: Cancer drug delivery has limitations of delivering hydrophobic anticancer drugs and non-targeted adverse effects to normal tissues. This work explores the self-assembling peptide EAK16-II for delivery of hydrophobic anticancer drug ellipticine in human lung carcinoma A549 cells. Hypothesis: Self-assembling peptide based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through an endocytotic mechanism. Methods: EAK16-II and ellipiticine were formulated in water, and size and morphology determined using transmission electron microscopy and dynamic light scattering. The anticancer activity was evaluated by MTS assay. The cellular uptake and subcellular distribution of drug was characterized using endocytotic inhibitors and trackers. Results: EAK16-II can form nanoparticles with ellipticine and has comparable anticancer activity to ellipticine in DMSO. Nano-formulation has enhanced drug uptake through the caveolin dependent pathway. The drug localizes to lysosome and target organelles. Conclusion: EAK16-II forms nanoparticles with the drug and enhances cellular uptake through a caveolin-dependent endocytotic mechanism.
author2 Liu, Mingyao
author_facet Liu, Mingyao
Bawa, Roli
author Bawa, Roli
spellingShingle Bawa, Roli
Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug
author_sort Bawa, Roli
title Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug
title_short Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug
title_full Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug
title_fullStr Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug
title_full_unstemmed Self-assembling Peptide Based Cellular Delivery of Hydrophobic Anticancer Drug
title_sort self-assembling peptide based cellular delivery of hydrophobic anticancer drug
publishDate 2009
url http://hdl.handle.net/1807/30120
work_keys_str_mv AT bawaroli selfassemblingpeptidebasedcellulardeliveryofhydrophobicanticancerdrug
_version_ 1716580800010387456